AzTrials
AzTrials

Overweight and ObesityNCT04915638

Intervention in Children With Malnutrition

A study testing Experimental intervention group with enriched cookies in people with Overweight and Obesity and Stunted Growth, run by Marta Alicia Menjivar Iraheta at 1 site in Mexico.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Malnutrition is an epidemiologic problem with high prevalence in Mexico. Mexican children present a double burden of malnutrition characterized by the coexistence of undernutrition and micronutrient deficiency alongside excess body weight. Read more about this study

Who is it for?
Ages 8 to 10 yearsHealthy volunteers can take part
What is being tested?
Experimental intervention group with enriched cookies
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteMexico
Study dates
15 Feb 2018to 12 Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children with Maya ethnicity confirmed by having parents and grandparents belonging to the same community, and three generations living in the community.
  • Children enrolled in 3th and 4th year of elementary school from the same educational center, volunteers, who have the informed consent signed by their parents or tutors, and the assent letter signed by children.
  • Aged between 8 to 10 years.
  • Both genders.

Who cannot join

  • Any child who does not want to participate in the study.
  • Children whose parents or tutors do not agree to sign the informed consent.
  • Children who do not sign the assent letter.
  • Age less than 8 years and older than 11 years.
  • Children using antihypertensive, hypoglycemic or lipid-lowering medications, as well as those that have a history of a condition affected by glucose metabolism, insulin or that alter body composition (cancer, chronic infections, food allergy).
  • Under treatment of intake of supplements with vitamins, minerals, antioxidants (<2 months).
  • Children with alcoholism or smoking.

Trial locations and contacts

1 site in 1 country.

Mexico1 site

  • Facultad de Química, Unidad Académica de la UNAM en Yucatán

    Mérida, Yucatán, 97302

Other trials in Mexico

About this study

Official title: Evaluation of Nutritional Status in Chimalhuacán Children: Anthropometric, Biochemical, and Molecular Approaches

Malnutrition is an epidemiologic problem with high prevalence in Mexico. Mexican children present a double burden of malnutrition characterized by the coexistence of undernutrition and micronutrient deficiency alongside excess body weight. Malnutrition is caused by inadequate nutrition, including micronutrients deficiencies, in which children living in rural areas and indigenous populations are disproportionately affected. Malnutrition has been associated with an increased risk of metabolic abnormalities like metabolic syndrome (MS), diabetes, and cardiovascular disease in adulthood. Nutrition-specific interventions are strategies that may reduce or avert malnutrition in children. However, limited intervention studies have been implemented in low-income populations, particularly in rural areas. Therefore, studies that include nutrition-specific intervention with enriched foods aimed at reducing micronutrients deficiencies and that can help in prevention or treatment of metabolic conditions in these populations are still needed. Based on the nutritional characterization carried out in school children in Chimalhuacán, Mexico State, a formula in a powder form was designed for children containing vitamins, minerals, antioxidants, and omega-3 fatty acids that can be used to enrich foods. The present study aimed to evaluate the effect of a 4-week intervention with cookies enriched with a micronutrient formula on the nutritional status in Maya schoolchildren aged 8-10 years. Participants (n=84) were their own control, and the investigators measured, at pre- and post-intervention, anthropometric, clinical, biochemical, and cognitive parameters; diet and molecular parameters were assessed only at pre-intervention. Chi-square test, t-Student paired or Wilcoxon, ANCOVA, and logistic regression were performed to analyze the data.

Read the detailed description

Mexican children face both forms of malnutrition: under- and overnutrition. Malnutrition is common among children living in rural areas and indigenous populations, where children suffer from food insecurity and cannot access quality nutrition with adequate micronutrients levels. Studies with vulnerable population groups, such as children, in Mexico have shown that micronutrient deficiencies of vitamins A, E, D, C, and minerals like iron, zinc, calcium, and selenium exist. Micronutrient deficiencies can affect physiology functions, growth of children, cognitive function, and impair metabolic processes at biochemical and cellular level. Furthermore, the early exposure of children to malnutrition, in conjunction with the existence of genetic susceptibility, may predispose children to develop metabolic abnormalities like metabolic syndrome (MetS). Thus, increasing the risk of children developing diabetes and cardiovascular diseases in adulthood.

The investigators decided to implement an intervention study in rural communities in the state of Yucatan because this region presents a higher proportion of Maya population than other states of Mexico, but also Yucatan has the highest prevalence of both obesity and undernutrition in children in the country. Previous studies from the investigators group in a Maya child population revealed a frequency of 50% MetS, 34.9% Insulin Resistance (IR), in addition to deficiencies of essential micronutrients. Despite the fact micronutrients are essential for adequate functioning of metabolic processes, few studies in Mexico propose an intervention with enriched food with multiple nutrients such as micronutrients and omega-3 fatty acids. Also, there is little evidence from micronutrient intervention studies in schoolchildren with malnutrition in Mexico, as a strategy to impact on nutritional status and preventive metabolic conditions. For instance, a study by García-López S et al in Mexican schoolchildren with overweight and MetS showed a decrease in lipid and glycemic profiles when supplemented with omega 3-fatty acids for 1 month. Therefore, the present study aimed to evaluate the effect of 4-week intervention with enriched cookies containing a micronutrient formula designed specifically to target the nutritional deficiencies identified in the children. The investigators assessed anthropometric, clinical, biochemical, and cognitive parameters; diet and molecular parameters were assessed only at pre-intervention.

  1. Study location: This study was conducted in three elementary schools of Maya rural communities of Yucatan. The communities are Xocén, Tahmek, and San José Oriente.
  2. Study design: This study was a paired clinical trial. Participants were their own control for the enriched food intervention.
  3. Sample size: The investigators used an equation for finite population. The sample size was estimated to have 80% of statistical power and 95% of a confidence level. A 15% was considered for calculations for dropout during the intervention. Based on the prevalence of malnutrition in Mexico and one community (Xocén), the total number of participants was 106.
  4. Sampling procedure: The investigators considered the inclusion and exclusion criterions. Participants were assigned with the convenience sampling technique.
  5. Intervention: The intervention consisted of a either a handmade oatmeal cookie or industrialized cookies both enriched with a formula FV-UNAM. The handmade oatmeal cookies enriched with the supplement formula were administered to schoolchildren from Xocén. The industrialized cookies, called Globitos, were donated by DONDÉ cookie factory company, and were supplemented with the same formula as the oatmeal cookies. The enriched Globitos were distributed to the schoolchildren from Tahmek and San José Oriente. The FV formula for children was designed by the Facultad de Química-UNAM. The FV formula is in powder form that contains vitamins, minerals, antioxidants, and omega-3 fatty acids, which are nutrients that have been observed to be deficient in the studied schoolchildren populations. The formulation was within the requirements of the Reference Daily Intake (RDI) for the Mexican population, according to their age, from the Official Mexican Standard (NOM)-051-SCFI/SSA1-2010.
  6. Measurements: A nutritional-clinical face-to-face interview was performed with parents or tutors and children. When necessary, assistance from a local translator was used. Nutritional data was collected before pre-intervention. Anthropometric, clinical, biochemical, and cognitive parameters were collected pre- and post-intervention; diet and molecular parameters were assessed only at pre-intervention.
  7. Anthropometric parameters were measured according to the International Society for the Advancement of Kinanthropometry (ISAK). Parameters included were: body weight (SECA 869), height (SECA 217); wrist, arm, and waist circumference (LUFKIN); tricipital skinfold (LANGE); wrist, humerus, and femur diameters (VITRUVIAN). Then, the BMI-for-age and height-for-age indicators were estimated and were translated to z-score according to the World Health Organization (WHO) classification for growth standards. Bone's diameters were translated to z-score and tricipital skinfold to percentile.
  8. Body composition (body fat and fat-free-mass) was determined by bioimpedance analysis (TANITA BC-1500).
  9. Blood pressure was taken twice with a rest period of 10 minutes. The investigators used the average of the two measurements and converted the value to percentile.
  10. Biochemical parameters were collected of peripheral blood samples (8ml) after 12 hours of fasting in the presence of parents or tutors. The 4ml was used for complete blood count and blood chemistry determinations, and also the molecular parameters. The rest of the sample (4ml) will be used for the determination of micronutrients in serum (vitamin A, vitamin E and vitamin D). Blood samples were centrifuged 15 minutes after sample collection and separated into aliquots. Aliquots were kept under optimal conditions (2-8◦C) until processing. All biochemical parameters were determined by the central laboratory of Hospital Juárez de México according to the specific instructions of the manufacturers of the commercial kits. The micronutrients will be quantified by high-efficiency liquid chromatography (HPLC).
  11. Cognitive test was assessed using a Draw-A-Person Intellectual Ability Test for Children, Adolescents and Adults (DAP:IQ), which allows an estimation of intellectual ability. The cognitive test was analyzed by two evaluators.
  12. Dietary intake was assessed using a standard 24-hour diet recall questionnaire at pre-intervention. This assessment consists of face-to-face interviews with parents or tutors, and children. The investigators used household measurements to estimate portion sizes of consumed foods and beverages. Dietary intake data was analyzed by a dietary analysis program (Nutrimind software). This software uses the Mexican Equivalent Food System and U.S. Department of agriculture (USDA) Food database.
  13. Frequency of food intake was estimated using the standard Semi-Quantitative Food Frequency Questionnaire (SFFQ), which was specific for the school age Mexican population. This assessment was a face-to-face interview with children in presence with the teacher. The SFFQ was analyzed using a valid method of Ramírez-Silva I et al., 2016.
  14. Molecular parameters included genotypification of genetic polymorphisms that are associated with metabolic alteration in Mexican adults and Mexico´s indigenous communities. First, the DNA genomic extraction from whole blood was performed using Miller technique. Polymorphisms of genes ATP (Adenosine triphosphate) binding cassette subfamily A member 1 (ABCA1), Peroxisome proliferator activated receptor gamma (PPARG), Glucokinase regulator (GCKR), Cycline-dependent kinase inhibitor-2A/B (CDKN2A/2B), Fat mass and obesity-associated (FTO), and Hepatocyte nuclear factor 4 alpha (HNF4A) were genotyped using TaqMan® probes in Real-time Polymerase Chain Reaction (qPCR) (QS5 from Applied Biosystem). The Hardy-Weinberg (H-W) equilibrium was verified. The allelic frequencies were obtained and were compared to 1000 Genomes Project reported frequencies.
  15. Adverse effects of the enriched cookies. Any adverse effects were assessed during a weekly visit. The information was obtained by teachers, parents or tutors.
  16. Ethics approval. The study protocol was approved by the Ethics Committee of Hospital Juárez de México (HJM2315/14-C).
  17. Data Analysis. Data was analyzed using the Statistical Program for Social Sciences (SPSS), version 20. Descriptive data was shown with tables pre- and post-intervention. Categorical variables were used as percentages. Continuous variables were tested for normality and were presented as mean and standard deviation. To determine significance of observed differences between pre- and post-intervention measurements the investigators used paired t-Student (parametric variables) and Wilcoxon (non-parametric) tests. An ANCOVA was performed to identify correlations between nutritional status and parameters, and was adjusted by age, gender, and BMI-z-score as fixed variables. Logistic regression was used to determine the effects of polymorphism under the risk of metabolic abnormality. A 95% confidence level was used, and a P value <0.05 was considered statistically significant.
Being tested
Experimental intervention group with enriched cookies
Keywords
Double burden of malnutrition, Enriched food, Micronutrients
Medical subject headings
Overweight, Obesity, Growth Disorders, Child Nutrition Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental intervention group with enriched cookiesDietary supplement

    Enriched cookies containing a micronutrients formula (vitamins, minerals, antioxidants, and omega-3 fatty acids) each day (Monday to Friday).

Study groups in NCT04915638
Study groupRoleWhat they receive
Intervention groupExperimentalSchoolchildren received enriched cookies containing a multiple micronutrients formula. Enriched cookies (20g) with a daily dose of 0.33g of organic mix formula were given in the morning during 4-weeks. The formulation is an industrial secret of UNAM.
Receives: Dietary Supplement: Experimental intervention group with enriched cookies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of weight from pre-intervention and after 4 weeks of intervention

    Kilograms

    Measured: Pre-intervention and post-intervention at week 4

  2. Change of height from pre-intervention and after 4 weeks of intervention

    Meters

    Measured: Pre-intervention and post-intervention at week 4

  3. Change of weight-for-age z-score from pre-intervention and after 4 weeks of intervention

    Measurement value of weight will be used to calculate weight-for-age in z-score according to age and sex

    Measured: Pre-intervention and post-intervention at week 4

  4. Change of height-for-age z-score from pre-intervention and after 4 weeks of intervention

    Measurement value of height will be used to calculate height-for-age in z-score according to age and sex

    Measured: Pre-intervention and post-intervention at week 4

  5. Change of Body Mass Index z-score from pre-intervention and after 4 weeks of intervention

    Weight and height will be combined to calculate Body Mass Index in kg/m^2. The value of BMI will be reported in BMI-for-age in z-score according to age and sex

    Measured: Pre-intervention and post-intervention at week 4

  6. Change of tricipital skinfold percentile from pre-intervention and after 4 weeks of intervention

    Tricipital skinfold will be reported in percentile according to age and sex

    Measured: Pre-intervention and post-intervention at week 4

  7. Change of bone diameters z-score from pre-intervention and after 4 weeks of intervention

    Bone diameters will be reported in z-score according to age and sex

    Measured: Pre-intervention and post-intervention at week 4

  8. Change of waist circumference percentile from pre-intervention and after 4 weeks of intervention

    Waist circumference will be reported in percentile according to age and sex

    Measured: Pre-intervention and post-intervention at week 4

  9. Change of waist-to-height ratio from pre-intervention and after 4 weeks of intervention

    Waist circumference height will be used to calculate waist-to-height ratio (WHtR)

    Measured: Pre-intervention and post-intervention at week 4

  10. Change of body fat-mass pre-intervention and after 4 weeks of intervention

    Percentage

    Measured: Pre-intervention and post-intervention at week 4

  11. Change of fat-free-mass pre-intervention and after 4 weeks of intervention

    Weight and body fat (converted to kg) will be used to calculate fat-free-mass in kilograms

    Measured: Pre-intervention and post-intervention at week 4

  12. Change in Systolic Blood Pressure pre-intervention and after 4 weeks of intervention

    Systolic Blood Pressure percentile according to age, sex, and height

    Measured: Pre-intervention and post-intervention at week 4

  13. Change of red blood count pre-intervention and after 4 weeks of intervention

    cell/microliter

    Measured: Pre-intervention and post-intervention at week 4

  14. Change of hemoglobin pre-intervention and after 4 weeks of intervention

    grams/deciliter

    Measured: Pre-intervention and post-intervention at week 4

  15. Change of hematocrit pre-intervention and after 4 weeks of intervention

    Percentage

    Measured: Pre-intervention and post-intervention at week 4

  16. Change of platelets pre-intervention and after 4 weeks of intervention

    Microliter

    Measured: Pre-intervention and post-intervention at week 4

  17. Change of white blood cells count in all cell types pre-intervention and after 4 weeks of intervention

    Reported value of neutrophils, eosinophils, lymphocytes, monocytes, and basophils in percentage

    Measured: Pre-intervention and post-intervention at week 4

  18. Change of glucose and lipid profile pre-intervention and after 4 weeks of intervention

    Glucose in milligrams/deciliter (mg/dL)

    Total cholesterol in mg/dL

    Triglycerides in mg/dL

    Low-density lipoproteins in mg/dL

    High-density lipoproteins in mg/dL

    Measured: Pre-intervention and post-intervention at week 4

  19. Change of liver profile pre-intervention and after 4 weeks of intervention

    Alanine aminotransferase in Unit/liter (U/L)

    Aspartate aminotransferase in U/L

    Measured: Pre-intervention and post-intervention at week 4

  20. Change of blood proteins pre-intervention and after 4 weeks of intervention

    Albumin in grams/deciliter (g/dL)

    Globulin in g/dL

    Total amount of albumin and globulin will be used to measure the total protein in g/dL

    Measured: Pre-intervention and post-intervention at week 4

  21. Change in cognitive test pre-intervention and after 4 weeks of intervention

    Standardized points of intellectual cognition based by a median of 100

    Measured: Pre-intervention and post-intervention at week 4

Secondary outcomes (7)

  1. Energy intake

    Energy intake will be estimated in kilocalories/day

    Measured: Pre-intervention, assessed up to 1 day

  2. Macronutrients intake in grams

    Carbohydrate, protein and fat intake will be estimated in grams

    Measured: Pre-intervention, assessed up to 1 day

  3. Macronutrients intake in percentage

    Carbohydrate, protein, and fat intake will be estimated in percentage

    Measured: Pre-intervention, assessed up to 1 day

  4. Micronutrients intake in micrograms

    Vitamin A intake will be estimate in micrograms

    Selenium intake will be estimated in micrograms

    Measured: Pre-intervention, assessed up to 1 day

  5. Micronutrients intake in milligrams

    Vitamin E and vitamin C intake will be estimated in milligrams

    Iron, calcium, and zinc will be estimated in milligrams

    Measured: Pre-intervention, assessed up to 1 day

  6. Frequency of food intake

    Frequencies of food consumption (Percentages)

    Measured: Pre-intervention, assessed up to 1 week

  7. Molecular parameters

    Allelic frequencies of each polymorphism of genes (Percentages)

    Measured: Pre-intervention, assessed up to 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2021
  2. Study start15 Feb 2018
  3. Primary completion12 Apr 2019
  4. Study completion12 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
The intervention consisted of enriched cookies given to children at school for one month. The intervention included two stages. First stage, schoolchildren received placebo cookies (20g of cookies without formula) each day (Monday to Friday) in the morning for 4 weeks. Then, in the second stage, schoolchildren received enriched cookies (20g with a formula FV-UNAM) each day (Monday to Friday) in the morning for 4 weeks. The formula was added to the cookies in a daily dose of 0.33g of organic mix that contained two vitamins, four minerals and omega-3 fatty acids. The exact composition of the formula is a trade secret held by UNAM. Schoolchildren were their own controls because the study was a paired study. In both stages we collected venous blood and anthropometric, blood pressure, and cognitive measurements before the placebo intervention, after 4 weeks from the beginning of formula intervention and post- intervention.
Masking
None (open label)
Enrolment
84 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04915638
Sponsor's protocol ID
HJM2315/14-C
Status last verified
May 2021
First submitted
18 May 2021
Last updated
7 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) not available because there is confidential data in the study.

Publications

  • Popkin BM, Corvalan C, Grummer-Strawn LM. Dynamics of the double burden of malnutrition and the changing nutrition reality. Lancet. 2020 Jan 4;395(10217):65-74. doi: 10.1016/S0140-6736(19)32497-3. Epub 2019 Dec 15.

    PubMed 31852602

  • Cuevas-Nasu L, Shamah-Levy T, Hernandez-Cordero SL, Gonzalez-Castell LD, Mendez Gomez-Humaran I, Avila-Arcos MA, Rivera-Dommarco JA. [Trends of malnutrition in Mexican children under five years from 1988 to 2016: Analysis of five national surveys]. Salud Publica Mex. 2018 May-Jun;60(3):283-290. doi: 10.21149/8846. Spanish.

    PubMed 29746745

  • Kroker-Lobos MF, Pedroza-Tobias A, Pedraza LS, Rivera JA. The double burden of undernutrition and excess body weight in Mexico. Am J Clin Nutr. 2014 Dec;100(6):1652S-8S. doi: 10.3945/ajcn.114.083832. Epub 2014 Oct 29.

    PubMed 25411308

  • Ramirez-Silva I, Rodriguez-Ramirez S, Barragan-Vazquez S, Castellanos-Gutierrez A, Reyes-Garcia A, Martinez-Pina A, Pedroza-Tobias A. Prevalence of inadequate intake of vitamins and minerals in the Mexican population correcting by nutrient retention factors, Ensanut 2016. Salud Publica Mex. 2020 Sep-Oct;62(5):521-531. doi: 10.21149/11096.

    PubMed 33027862

  • Duggan MB. Prevention of childhood malnutrition: immensity of the challenge and variety of strategies. Paediatr Int Child Health. 2014 Nov;34(4):271-8. doi: 10.1179/2046905514Y.0000000139. Epub 2014 Aug 27.

    PubMed 25161059

  • Tam E, Keats EC, Rind F, Das JK, Bhutta AZA. Micronutrient Supplementation and Fortification Interventions on Health and Development Outcomes among Children Under-Five in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Nutrients. 2020 Jan 21;12(2):289. doi: 10.3390/nu12020289.

    PubMed 31973225

  • Martini L, Pecoraro L, Salvottini C, Piacentini G, Atkinson R, Pietrobelli A. Appropriate and inappropriate vitamin supplementation in children. J Nutr Sci. 2020 Jun 5;9:e20. doi: 10.1017/jns.2020.12.

    PubMed 32577225

  • Garcia OP, Ronquillo D, del Carmen Caamano M, Martinez G, Camacho M, Lopez V, Rosado JL. Zinc, iron and vitamins A, C and e are associated with obesity, inflammation, lipid profile and insulin resistance in Mexican school-aged children. Nutrients. 2013 Dec 10;5(12):5012-30. doi: 10.3390/nu5125012.

    PubMed 24335710

  • Wells JC, Sawaya AL, Wibaek R, Mwangome M, Poullas MS, Yajnik CS, Demaio A. The double burden of malnutrition: aetiological pathways and consequences for health. Lancet. 2020 Jan 4;395(10217):75-88. doi: 10.1016/S0140-6736(19)32472-9. Epub 2019 Dec 15.

    PubMed 31852605

  • Garcia-Lopez S, Villanueva Arriaga RE, Najera Medina O, Rodriguez Lopez CP, Figueroa-Valverde L, Cervera EG, Munozcano Skidmore O, Rosas-Nexticapa M. One month of omega-3 fatty acid supplementation improves lipid profiles, glucose levels and blood pressure in overweight schoolchildren with metabolic syndrome. J Pediatr Endocrinol Metab. 2016 Oct 1;29(10):1143-1150. doi: 10.1515/jpem-2015-0324.

    PubMed 27658130

  • de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007 Sep;85(9):660-7. doi: 10.2471/blt.07.043497.

    PubMed 18026621

  • Imuta K, Scarf D, Pharo H, Hayne H. Drawing a close to the use of human figure drawings as a projective measure of intelligence. PLoS One. 2013;8(3):e58991. doi: 10.1371/journal.pone.0058991. Epub 2013 Mar 14.

    PubMed 23516590

  • Ramirez-Silva I, Jimenez-Aguilar A, Valenzuela-Bravo D, Martinez-Tapia B, Rodriguez-Ramirez S, Gaona-Pineda EB, Angulo-Estrada S, Shamah-Levy T. Methodology for estimating dietary data from the semi-quantitative food frequency questionnaire of the Mexican National Health and Nutrition Survey 2012. Salud Publica Mex. 2016 Nov-Dec;58(6):629-638. doi: 10.21149/spm.v58i6.7974.

    PubMed 28225939

  • Lara-Riegos JC, Ortiz-Lopez MG, Pena-Espinoza BI, Montufar-Robles I, Pena-Rico MA, Sanchez-Pozos K, Granados-Silvestre MA, Menjivar M. Diabetes susceptibility in Mayas: Evidence for the involvement of polymorphisms in HHEX, HNF4alpha, KCNJ11, PPARgamma, CDKN2A/2B, SLC30A8, CDC123/CAMK1D, TCF7L2, ABCA1 and SLC16A11 genes. Gene. 2015 Jul 1;565(1):68-75. doi: 10.1016/j.gene.2015.03.065. Epub 2015 Mar 31.

    PubMed 25839936

  • Moreno-Estrada A, Gignoux CR, Fernandez-Lopez JC, Zakharia F, Sikora M, Contreras AV, Acuna-Alonzo V, Sandoval K, Eng C, Romero-Hidalgo S, Ortiz-Tello P, Robles V, Kenny EE, Nuno-Arana I, Barquera-Lozano R, Macin-Perez G, Granados-Arriola J, Huntsman S, Galanter JM, Via M, Ford JG, Chapela R, Rodriguez-Cintron W, Rodriguez-Santana JR, Romieu I, Sienra-Monge JJ, del Rio Navarro B, London SJ, Ruiz-Linares A, Garcia-Herrera R, Estrada K, Hidalgo-Miranda A, Jimenez-Sanchez G, Carnevale A, Soberon X, Canizales-Quinteros S, Rangel-Villalobos H, Silva-Zolezzi I, Burchard EG, Bustamante CD. Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. Science. 2014 Jun 13;344(6189):1280-5. doi: 10.1126/science.1251688. Epub 2014 Jun 12.

    PubMed 24926019

Questions about this trial

What is this clinical trial studying?

A study testing Experimental intervention group with enriched cookies in people with Overweight and Obesity and Stunted Growth, run by Marta Alicia Menjivar Iraheta at 1 site in Mexico.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of weight from pre-intervention and after 4 weeks of intervention (time frame: Pre-intervention and post-intervention at week 4). The study lists 21 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04915638, which also lists 23 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2021.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in